Correlation Between CanSino Biologics and 4Front Ventures

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CanSino Biologics and 4Front Ventures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CanSino Biologics and 4Front Ventures into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CanSino Biologics and 4Front Ventures Corp, you can compare the effects of market volatilities on CanSino Biologics and 4Front Ventures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CanSino Biologics with a short position of 4Front Ventures. Check out your portfolio center. Please also check ongoing floating volatility patterns of CanSino Biologics and 4Front Ventures.

Diversification Opportunities for CanSino Biologics and 4Front Ventures

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between CanSino and 4Front is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding CanSino Biologics and 4Front Ventures Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4Front Ventures Corp and CanSino Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CanSino Biologics are associated (or correlated) with 4Front Ventures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4Front Ventures Corp has no effect on the direction of CanSino Biologics i.e., CanSino Biologics and 4Front Ventures go up and down completely randomly.

Pair Corralation between CanSino Biologics and 4Front Ventures

Assuming the 90 days horizon CanSino Biologics is expected to generate 0.39 times more return on investment than 4Front Ventures. However, CanSino Biologics is 2.55 times less risky than 4Front Ventures. It trades about 0.15 of its potential returns per unit of risk. 4Front Ventures Corp is currently generating about -0.31 per unit of risk. If you would invest  390.00  in CanSino Biologics on September 13, 2024 and sell it today you would earn a total of  45.00  from holding CanSino Biologics or generate 11.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

CanSino Biologics  vs.  4Front Ventures Corp

 Performance 
       Timeline  
CanSino Biologics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, CanSino Biologics reported solid returns over the last few months and may actually be approaching a breakup point.
4Front Ventures Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4Front Ventures Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

CanSino Biologics and 4Front Ventures Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CanSino Biologics and 4Front Ventures

The main advantage of trading using opposite CanSino Biologics and 4Front Ventures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CanSino Biologics position performs unexpectedly, 4Front Ventures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4Front Ventures will offset losses from the drop in 4Front Ventures' long position.
The idea behind CanSino Biologics and 4Front Ventures Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation